Western New York Veteran Affairs Healthcare System, University at Buffalo, Buffalo, NY, USA.
Sleep Breath. 2012 Sep;16(3):609-15. doi: 10.1007/s11325-011-0546-5. Epub 2011 Jun 27.
Patients with sleep apnea (OSA) have an increased risk of perioperative complications.
The purpose of this study is to assess whether OSA increases the risk of cardio-respiratory complications in patients undergoing endoscopic procedures with conscious sedation.
A prospective study over a 7-month period was performed. All patients undergoing upper, lower, or combined endoscopy were asked to fill in the Berlin questionnaire. The questionnaire was scored, and patients were classified as high or low risk for sleep apnea based on the suggested scoring criteria. Patients who had previously undergone a sleep study were excluded. Demographics and co-morbidities were identified from the electronic medical record. Procedure type, amount of sedation, and minor and major complications were identified from the endoscopy flow sheet. The minor complications were defined as hypertension, hypotension, bradycardia, tachycardia, hypoxemia, and bradypnea (respiratory rate <8 breaths/min). Major complications included chest pain, arrhythmia, altered mental status, respiratory distress, and a minor complication that required a significant intervention, such as use of a reversal agent, atropine, up-titration of oxygen for hypoxemia, or prolonged observation.
Procedures were performed in 904 patients: colonoscopies, 68.0%; upper endoscopies, 22.8%; and combined procedures, 9.2%. Five hundred fifty-three patients were identified as low risk (61.2%), and 351 were identified as high risk (38.8%). The mean age was 59.5 ± 10.5 years, mean body mass index was 28.9 ± 6.6, mean neck circumference was 16.2 ± 6.3 in., and 91.4% were males. The median Charlson co-morbidity index was 1 (25-75% percentage range 0-2). All patients received midazolam and fentanyl during endoscopy. The median and 25-75% range for midazolam and fentanyl dosages were 5 mg, 4-6 mg and 100 μg, 75-125 μg, respectively. Minor complications were observed in 10.56% of low-risk patients and 10.63% of high-risk patients (p = not significant (NS); odds ratio, 1.01; 95% confidence interval 0.65-1.56). Major complications were observed in 3.25% of low-risk patients and 1.9% of high-risk patients (p = ns; odds ratio, 0.6; 95% confidence interval 0.26-1.46).
For patients undergoing endoscopy procedures under conscious sedation, the presence of OSA does not clearly increase the risk of cardiopulmonary complications.
患有睡眠呼吸暂停(OSA)的患者围手术期并发症的风险增加。
本研究旨在评估 OSA 是否会增加接受内镜检查镇静患者的心肺并发症风险。
进行了为期 7 个月的前瞻性研究。所有接受上、下或联合内镜检查的患者均被要求填写柏林问卷。根据建议的评分标准对问卷进行评分,并将患者分为睡眠呼吸暂停高风险或低风险。已进行睡眠研究的患者被排除在外。从电子病历中确定人口统计学和合并症。从内镜流程表中确定手术类型、镇静剂用量以及小并发症和大并发症。小并发症定义为高血压、低血压、心动过缓、心动过速、低氧血症和呼吸过缓(呼吸频率<8 次/分钟)。大并发症包括胸痛、心律失常、意识状态改变、呼吸窘迫以及需要显著干预的小并发症,如使用逆转剂、阿托品、增加氧气治疗低氧血症或延长观察时间。
904 例患者进行了检查:结肠镜检查,68.0%;上消化道内镜检查,22.8%;联合检查,9.2%。553 例患者被确定为低风险(61.2%),351 例患者被确定为高风险(38.8%)。平均年龄为 59.5±10.5 岁,平均体重指数为 28.9±6.6,平均颈围为 16.2±6.3 英寸,91.4%为男性。中位 Charlson 合并症指数为 1(25-75%范围 0-2)。所有患者在内镜检查期间均接受咪达唑仑和芬太尼。咪达唑仑和芬太尼剂量的中位数和 25-75%范围分别为 5mg、4-6mg 和 100μg、75-125μg。低风险患者中观察到 10.56%的小并发症,高风险患者中观察到 10.63%(p=无统计学意义(NS);优势比,1.01;95%置信区间 0.65-1.56)。低风险患者中观察到 3.25%的大并发症,高风险患者中观察到 1.9%(p=无统计学意义(NS);优势比,0.6;95%置信区间 0.26-1.46)。
对于接受镇静内镜检查的患者,OSA 的存在并不能明显增加心肺并发症的风险。